| Metric | შპს Linema Pharm | შპს ირისე |
|---|---|---|
| Growth | ||
| Revenue | ₾3.9m₾1.6m | ₾3.6m₾4.2m |
| Revenue growth | 139.8% | -16.1% |
| Profitability | ||
| EBITDA | ₾1.3m₾465k | ₾545k₾934k |
| EBITDA margin | 32.2%28.7% | 15.3%22.0% |
| Net profit | ₾1.2m-₾90k | ₾378k₾747k |
| Net margin | 31.0%-5.5% | 10.6%17.6% |
| Balance sheet | ||
| Total assets | ₾7.5m₾6.2m | ₾2.5m₾2.6m |
| Total equity | ₾6.4m₾5.4m | ₾2.1m₾2.3m |
| ROE | 18.9%-1.6% | 18.2%32.9% |